Finasteride
Product Images NDC 65977-5025

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 65977-5025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hetero Drugs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Address.jpg (Address)

Packaging label showing the manufacturer as Hetero Labs Limited, located at 22-110, I.D.A., Jeedimetla, Hyderabad, India. The image includes the Hetero logo and a barcode area. No proprietary name or dosage form is visible in the image.*

FDA Label Image

Address2.jpg (Address2)

The label contains manufacturer information for Finasteride, showing it is manufactured by HETERO LABS LIMITED, located at 22-110, I.D.A., Jeedimetla, Hyderabad - 500 055, India, with the Hetero logo present.*

FDA Label Image

Figure1.jpg (Figure1)

A line graph comparing the mean change from baseline over four years between Finasteride and placebo groups. The vertical axis shows mean change, and the horizontal axis indicates time points from baseline through year 4. Data points illustrate a greater decrease in the Finasteride group compared to the relatively stable placebo group.*

FDA Label Image

Figure2.jpg (Figure2)

Line graph titled 'Percent of Patients Having Surgery for BPH, Including TURP,' comparing percentages over 48 months for patients treated with Finasteride and placebo. The graph includes a table showing cumulative number of events and patients at risk per year for both groups at multiple time points.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the mean percent change from baseline ± 1 standard error for two groups: placebo and finasteride, over a period from baseline to year 4. The placebo group shows an increasing trend, while the finasteride group demonstrates a decreasing trend in mean percent change, with sample sizes listed for each time point.*

FDA Label Image

Containerlabel.jpg (Containerlabel)

Label for Finasteride Tablets USP 5 mg, containing 30 film-coated tablets. The label includes storage instructions, a warning about use by women or children, and states the product is Rx only. Manufactured by Hetero Labs Limited in Hyderabad, India. The NDC number 65977-5025-0 is shown.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of the active ingredient Finasteride, showing its molecular framework with labeled atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.